老年持续性房颤患者减重:LOSE-AF随机临床试验
这项在2家英国医院开展的平行组非盲随机临床试验,纳入118例60至85岁、BMI≥27的持续性房颤患者,比较8个月低热量饮食加行为支持与常规护理。
要点
- 老年超重持续性房颤患者8个月低热量饮食加行为支持可实现显著减重。
- 减重未显著改善房颤症状严重度、房颤负荷或心脏重构指标。
- 试验期间未报告与参与相关的严重不良事件。
核心结论
- 在老年超重合并持续性房颤患者中,8个月低热量饮食加行为支持带来显著减重且无安全性顾虑,但未影响房颤症状、房颤负荷、心脏重构或进一步节律控制干预需求。
研究设计与样本
- 平行组、非盲随机临床试验,2018年11月14日至2025年4月25日在2家英国医院开展。
- 约1500例因房颤接受电复律者接受资格评估,约500例60至85岁、BMI≥27且无排除标准者被邀请参与。
- 119例提供知情同意,118例随机分组:干预组59例接受8个月低热量饮食加行为支持,对照组59例接受常规护理。
- 主要分析为意向性分析,比较随机后8个月房颤严重度量表(AFSS)症状严重度评分变化。
主要发现
- 118例参与者平均年龄68岁(SD,6),女性占33%。
- 8个月时基线校正平均体重干预组为92.6 kg(SE,0.85),对照组为99.4 kg(SE,0.85),P<.001,估计差值为-6.9 kg(95%CI,-9.2至-4.5)。
- 体重降幅分别为9.7%与3.1%(P<.001)。
- 8个月时基线校正平均AFSS症状严重度评分干预组为7.9(SE,0.84),对照组为8.9(SE,0.84),组间差值-0.9(95%CI,-3.3至1.4),P=.43。
- 身体活动能力、房颤负荷、心脏影像参数、血压、血脂谱及随访期间重复电复律或房颤消融发生率均未见显著治疗效应,两组均未报告与参与试验相关的严重不良事件。
临床怎么用
- 对老年超重合并持续性房颤患者,低热量饮食加行为支持可有效减重且短期安全性可接受。
- 不应仅以改善房颤症状、房颤负荷或心脏重构为目的对老年患者推行该减重干预。
局限性
- 样本量较小(118例随机),可能不足以检出症状等指标的较小差异。
- 研究为非盲设计,可能影响患者报告结局。
- 随访8个月,无法评估长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Excess body weight is a strong risk factor for atrial fibrillation (AF), and weight loss is recommended in clinical guidelines for all patients with obesity and AF. However, existing evidence derives from younger patients, and weight loss in older adults could precipitate frailty. OBJECTIVE: To investigate whether weight loss is a safe and effective intervention in older patients with overweight and AF. DESIGN, SETTING, AND PARTICIPANTS: Parallel-group, unblinded, randomized clinical trial conducted at 2 UK hospitals from November 14, 2018, to April 25, 2025. Approximately 1500 individuals undergoing electrical cardioversion for AF were assessed for eligibility, and approximately 500 aged 60 to 85 years with body mass index 27 or greater and without any exclusion criteria were invited to participate. Of these, 119 provided informed consent to enter the trial and 118 were randomized. INTERVENTION: Participants were randomized to an 8-month low-calorie diet and behavioral support program (intervention, n = 59) or to usual care (control, n = 59). MAIN OUTCOME AND MEASURE: Intention-to-treat analysis of the change in Atrial Fibrillation Severity Scale (AFSS) symptom severity score at 8 months after randomization. RESULTS: Participants (n = 118) had a mean age of 68 years (SD, 6); 33% were female. The intervention resulted in significantly lower weight (baseline-adjusted mean weight at 8 months: 92.6 [SE, 0.85] kg vs 99.4 [SE, 0.85] kg; P < .001; estimated difference, -6.9 kg [95% CI, -9.2 to -4.5]). This corresponded to a weight reduction of 9.7% vs 3.1%, respectively (P < .001). However, there were no significant differences between the groups in AFSS symptom severity score (baseline-adjusted mean at 8 months, 7.9 [SE, 0.84] in the intervention group vs 8.9 [SE, 0.84] in the control group; between-group difference, -0.9 [95% CI, -3.3 to 1.4]; P = .43). No significant treatment effects were observed on physical performance, AF burden, cardiac imaging parameters, blood pressure, lipid profile, or incidence of repeat cardioversion or AF ablation during follow-up. No serious adverse events related to participation in the trial were reported in either group. CONCLUSIONS AND RELEVANCE: In older patients with overweight and persistent AF, a low-calorie diet and behavioral support program was associated with significant weight loss at 8 months with no safety concerns but did not affect AF symptoms, AF burden, cardiac remodeling, or the need for further rhythm control interventions. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03713775.
引用
- Sclafani M, Spartera M, Esmati Y, et al. Weight Loss in Older Patients With Persistent Atrial Fibrillation: The LOSE-AF Randomized Clinical Trial. JAMA. 2026. PMID: 42160044. doi:10.1001/jama.2026.5787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。